Donna Zemlickis
- Oncology top 5%
- Cancer Risks and Factors 7
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- Obstetrics and Gynecology top 5%
-
- Childhood Cancer Survivors' Quality of Life 4
- Reproductive Medicine top 10%
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Acute Lymphoblastic Leukemia research 3
-
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Gideon KorenMichael LishnerTony PanzarellaPamela DegendorferSimon SutcliffeJulia KleinMelissa L. JohnsonMatthew Krebs
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Donna Zemlickis
16 papers receiving 659 citations
Peers
Comparison fields: 5 of 50
- Oncology 584
- Obstetrics and Gynecology 104
- Pediatrics, Perinatology and Child Health 232
- Reproductive Medicine 58
- Epidemiology 232
Countries citing papers authored by Donna Zemlickis
This map shows the geographic impact of Donna Zemlickis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Zemlickis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Zemlickis more than expected).
Fields of papers citing papers by Donna Zemlickis
This network shows the impact of papers produced by Donna Zemlickis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Zemlickis. The network helps show where Donna Zemlickis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donna Zemlickis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 1 | |
| 8 | 1994 | 21 | |
| 9 | 1994 | 25 | |
| 10 | 1993 | 71 | |
| 11 | 1992 | 94 | |
| 12 | 1992 | 141 | |
| 13 | 1992 | 10 | |
| 14 | 1992 | 196 | |
| 15 | 1991 | 12 | |
| 16 | 1991 | 98 |
About Donna Zemlickis
Donna Zemlickis is a scholar working on Oncology, Hematology and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 686 indexed citations. Recurring topics across this work include Cancer Risks and Factors (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Peptidase Inhibition and Analysis (3 papers), Multiple Myeloma Research and Treatments (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (584 citations), Obstetrics and Gynecology (104 citations) and Pediatrics, Perinatology and Child Health (232 citations). Donna Zemlickis has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Gideon Koren, Michael Lishner, Tony Panzarella, Pamela Degendorfer, Simon Sutcliffe, Gideon Koren, Julia Klein, Melissa L. Johnson, Matthew Krebs and Nahor Haddish‐Berhane.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.